middl
east
respiratori
syndrom
coronaviru
merscov
first
isol
patient
suffer
sever
respiratori
ill
saudi
juli
total
case
countri
report
world
health
organ
death
case
fatal
rate
http
wwwwhointemergenciesmerscoven
similar
sever
acut
respiratori
syndrom
sarscov
merscov
emerg
result
zoonot
introduct
human
consid
ongo
merscov
outbreak
crucial
develop
intervent
measur
includ
current
licens
therapeut
treatment
vaccin
avail
highlight
urgent
need
develop
effect
vaccin
merscov
merscov
genom
encod
nonstructur
protein
four
structur
spike
small
envelop
e
membran
nucleocapsid
n
protein
viral
structur
protein
n
show
highest
protein
mediat
coronaviru
entri
host
cell
first
bind
receptor
hostcel
surfac
via
receptorbind
domain
rbd
although
n
protein
induc
tcell
respons
neutral
antibodi
almost
sole
direct
protein
major
immunodomin
factor
thu
current
merscov
vaccin
candid
primarili
use
protein
part
gene
code
vaccin
merscov
infect
develop
use
purifi
coronaviru
protein
well
dna
viral
vectorbas
vaccin
express
fulllength
merscov
protein
part
vaccin
test
abil
induc
virusneutr
antibodi
mice
larg
anim
monkey
sever
mer
vaccin
develop
among
vaccin
platform
shown
confer
variabl
degre
immunogen
necessit
adjust
dose
adjuv
site
administr
induc
optim
protect
furthermor
ongo
effort
develop
merscov
vaccin
consid
immun
profil
differ
antigen
correl
protect
ideal
mer
vaccin
induc
potent
neutral
antibodi
respons
without
induc
harm
immun
effect
virusenhanc
antibodi
immunopatholog
sever
previou
report
rel
inactiv
sarscov
merscov
vaccin
led
safeti
concern
reminisc
report
mice
given
formalininactiv
wholeviru
respiratori
syncyti
viru
rsv
vaccin
challeng
infecti
howev
preclin
evalu
subunit
inactiv
wholeviru
vaccin
adjuv
sarscov
shown
induct
serum
neutral
antibodi
protect
infect
mice
challeng
infecti
therefor
appropri
adjuv
even
adjuv
combin
requir
effect
safe
vaccin
formul
cpg
oligodeoxynucleotid
name
cpg
short
synthet
dna
sequenc
consist
unmethyl
cg
dinucleotid
current
develop
vaccin
adjuv
promot
immun
previou
data
demonstr
advantag
combin
two
adjuv
cpg
alum
induct
immun
current
studi
determin
effect
inactiv
whole
merscov
iv
protein
vaccin
combin
alumcpg
adjuv
protect
merscov
risk
lung
immunopatholog
mice
furthermor
vaccin
iv
formul
contain
structur
protein
n
e
protein
enhanc
protect
merscov
well
led
reduc
viral
antigen
express
patholog
damag
almost
viru
isol
lung
mice
postchalleng
immunogen
iv
protein
first
character
western
blot
use
anti
fig
antin
monoclon
fig
antibodi
produc
protein
migrat
three
polypeptid
specif
recogn
antibodi
western
blot
analysi
band
repres
monom
protein
ectodomain
band
repres
glycoprotein
cleavag
aminotermin
domain
band
might
repres
dimer
iv
migrat
two
polypeptid
upper
band
repres
nglycosyl
fulllength
protein
lower
band
repres
addit
iv
load
onto
gel
character
western
blot
use
antin
mous
monoclon
antibodi
produc
laboratori
fig
result
show
band
predict
molecular
mass
iv
previou
assess
immun
induc
vaccin
develop
protein
iv
combin
adjuv
adult
femal
balbc
mice
six
per
group
given
three
im
immun
interv
combin
adjuv
alon
formul
either
protein
iv
dosag
protein
fig
first
prime
week
robust
proteinspecif
immunoglobulin
respons
detect
iv
vaccin
group
titer
mice
immun
iv
significantli
higher
titer
immun
antigen
fig
second
immun
proteinspecif
igg
titer
week
significantli
differ
protein
iv
vaccin
group
fig
howev
proteinspecif
igg
titer
increas
either
group
third
immun
igg
isotyp
protein
induc
vaccin
test
week
anti
protein
induc
protein
iv
vaccin
group
fig
ratio
balanc
immun
respons
protein
vaccin
group
howev
ratio
immun
respons
iv
vaccin
group
next
evalu
n
e
mspecif
immun
respons
mice
receiv
vaccin
signific
npspecif
igg
antibodi
induc
mice
week
first
immun
iv
receiv
protein
vaccin
adjuv
alon
fig
robust
npspecif
igg
titer
reach
dilut
serum
mice
receiv
iv
vaccin
second
immun
week
third
immun
npspecif
igg
respons
enhanc
mice
receiv
iv
vaccin
sampl
collect
cell
transient
transfect
pcaggs
e
pcaggsm
control
pcagg
plasmid
h
posttransfect
subject
western
blot
fig
ifa
fig
use
iv
proteinimmun
mous
serum
primari
antibodi
dilut
e
detect
predict
size
ivimmun
mous
serum
indic
induct
e
mspecif
immun
respons
ifa
result
demonstr
specif
stain
mers
protein
also
observ
ivimmun
mous
serum
use
primari
antibodi
howev
specif
band
stain
detect
use
simmun
mous
serum
primari
antibodi
data
shown
mous
sera
subject
pseudoviru
neutral
prnt
assay
second
immun
serum
merscov
neutral
assay
result
larg
mirror
proteinspecif
igg
result
notabl
except
serum
mersneutr
antibodi
detect
mock
group
group
prevaccin
robust
neutral
antibodi
respons
elicit
protein
iv
combin
adjuv
formul
week
basi
pseudoviru
neutral
assay
sera
dilut
show
neutral
activ
iv
group
significantli
higher
protein
group
neutral
activ
fig
howev
signific
differ
neutral
activ
sera
found
protein
iv
group
third
immun
week
sera
dilut
show
neutral
activ
protein
iv
group
fig
basi
prnt
assay
sera
dilut
show
neutral
activ
iv
group
week
significantli
higher
protein
group
neutral
activ
fig
signific
neutral
activ
differ
sera
found
protein
iv
group
third
immun
week
sera
dilut
show
neutral
activ
protein
iv
group
fig
repres
microscopi
graph
rrnt
assay
shown
fig
shown
data
consist
pseudoviru
neutral
prnt
assay
evalu
cmi
mice
euthan
splenocyt
isol
week
final
immun
week
howev
signific
cmi
antigen
includ
n
e
protein
detect
mice
elispot
assay
use
sever
synthes
peptid
librari
overlap
e
n
protein
merscov
data
shown
assess
effect
vaccin
mous
lung
multipl
independ
site
lung
tissu
sampl
subject
ie
ihc
analys
day
postchalleng
shown
fig
sever
lesion
includ
loss
pulmonari
alveoli
diffus
inflammatori
cell
infiltr
detect
lung
tissu
control
mice
contrast
milder
lesion
observ
mice
immun
protein
iv
pulmonari
alveolu
visibl
infiltr
inflammatori
cell
less
mark
sever
scale
none
mild
moder
sever
adjuv
alon
group
grade
mononuclear
cell
infiltr
includ
lymphocyt
macrophagesmonocyt
vaccin
group
grade
day
postchalleng
result
indic
protein
iv
vaccin
amelior
respiratori
tract
patholog
mice
challeng
merscov
fig
addit
n
protein
express
detect
lung
tissu
immun
group
fig
indic
protect
incomplet
howev
either
protein
np
express
weaker
lung
mice
immun
iv
compar
immun
assess
abil
vaccin
formul
inhibit
merscov
replic
lung
homogen
lung
tissu
mice
kill
day
postchalleng
subject
viru
isol
titrat
day
postchalleng
adjuv
vaccin
group
significantli
lower
lung
viru
titer
compar
adjuvantalon
group
furthermor
signific
differ
lung
viru
titer
detect
two
vaccin
formul
day
postchalleng
lowest
lung
viru
titer
almost
zero
found
group
receiv
iv
antigen
formul
combin
adjuv
fig
therefor
vaccin
iv
induc
effect
protect
immun
mice
compar
vaccin
protein
studi
assess
protect
efficaci
protein
iv
antigen
merscov
viru
infect
lung
immunopatholog
latter
previous
report
exacerb
alumformul
data
suggest
protein
iv
vaccin
formul
combin
adjuv
induc
protect
safe
immun
mice
enhanc
protect
induc
iv
vaccin
contain
combin
adjuv
significantli
correl
antigenspecif
immun
structur
protein
n
e
compar
vaccin
formul
protein
merscov
howev
also
could
complet
exclud
impact
qualiti
antibodi
respons
viral
spike
use
recombin
protein
versu
present
inactiv
viru
need
clarifi
report
immun
iv
lead
lung
immunopatholog
mice
upon
challeng
live
therefor
inactiv
merscov
vaccin
may
present
risk
hypersensitivetyp
lung
patholog
follow
merscov
infect
similar
work
differ
tseng
et
al
sever
respect
includ
prepar
iv
inactiv
formaldehyd
vs
gamma
irradi
adjuv
formul
alcpg
vs
al
anim
model
transduc
mice
vs
transgen
mice
differ
might
contribut
differ
phenotyp
effect
without
enhanc
lung
patholog
vs
increas
infiltr
contain
eosinophil
mice
iv
two
studi
regard
immun
patholog
postchalleng
therefor
work
need
explor
adjuv
activ
cpgalum
combin
protein
iv
vaccineinduc
immun
mice
known
protein
iv
vaccin
alum
adjuv
induc
respons
data
demonstr
advantag
combin
two
adjuv
name
cpg
alum
induct
robust
antibodi
respons
proteinspecif
igg
titer
reach
neutral
activ
achiev
sera
dilut
vaccin
group
second
immun
addit
vaccin
formul
cpgalum
combin
gener
balanc
respons
protein
mice
vaccin
protein
iv
respect
balanc
immun
respons
gener
associ
effect
control
viral
infect
fig
mice
immun
iv
produc
anti
antibodi
immun
recombin
spike
protein
post
immun
group
believ
differ
might
caus
particlelik
conform
protein
preserv
immunogen
iv
compar
recombin
protein
solubl
subunit
n
protein
cov
character
high
humor
cellular
e
protein
structur
protein
anchor
envelop
merscov
e
protein
small
integr
membran
polypeptid
form
ion
protein
typic
transmembran
glycoprotein
abund
structur
protein
cov
buchholz
et
report
e
protein
express
vector
induc
detect
resist
sarscov
challeng
hamster
howev
report
suggest
play
signific
role
virusspecif
humor
respons
induc
product
neutral
antibodi
sar
addit
n
e
protein
may
antigen
antivir
cytotox
cell
induc
shortterm
resist
viru
challeng
absenc
monoclon
antibodi
mice
shown
case
sever
studi
protein
iv
vaccin
induc
almost
ident
protein
antigenspecif
igg
antibodi
respons
neutral
activ
last
immun
howev
antigenspecif
humor
immun
respons
structur
protein
n
e
protein
detect
mice
iv
addit
level
protein
n
protein
express
lung
mice
receiv
iv
slightli
lower
mice
receiv
protein
vaccin
furthermor
mild
patholog
lower
viru
titer
detect
lung
mice
receiv
iv
fig
indic
iv
formul
induc
greater
protect
effect
mice
protein
formul
therefor
find
indic
enhanc
protect
effect
might
deriv
antibodi
n
e
structur
protein
contain
iv
conclus
novel
iv
formul
inactiv
formaldehyd
contain
alumcpg
adjuv
induc
protect
immun
result
enhanc
pulmonari
immunopatholog
highlight
import
inactiv
strategi
adjuv
interest
although
iv
formul
induc
similar
level
anti
protein
igg
respons
neutral
activ
iv
formul
induc
greater
protect
effect
mice
protein
formul
suggest
immun
iv
formul
induc
enhanc
protect
mice
compar
protein
merscov
test
camel
clinic
trial
anim
studi
conduct
strict
accord
guid
care
use
laboratori
anim
peopl
republ
china
studi
protocol
approv
committe
ethic
anim
experi
chines
centr
diseas
control
prevent
china
cdc
experiment
procedur
perform
ethyleth
anesthesia
everi
effort
made
minim
suffer
follow
inocul
merscov
experi
conduct
anim
biosafeti
level
facil
construct
accredit
accord
nation
standard
laboratori
anim
scienc
chines
academi
medic
scienc
peke
union
medic
colleg
beij
china
purifi
recombin
protein
sino
biolog
inc
beij
china
deriv
baculovirusinsect
cell
express
extracellular
domain
spike
protein
merscov
human
beta
coronaviru
compris
amino
acid
merscov
strain
kindli
provid
professor
ron
fouchier
erasmu
medic
centr
rotterdam
netherland
viru
propag
vero
cell
american
type
cultur
collect
manassa
va
usa
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
intern
unitsml
penicillin
streptomycin
experi
relat
live
merscov
perform
accord
standard
oper
procedur
biosafeti
facil
china
cdc
quantifi
merscov
inactiv
formaldehyd
day
inactiv
merscov
iv
centrifug
rpm
min
supernat
collect
confirm
noninfecti
titrat
vero
cell
subsequ
supernat
concentr
centrifug
rpm
h
pellet
collect
dissolv
phosphatebuff
salin
pb
overnight
concentr
iv
quantifi
use
bcabas
protein
quantif
kit
applygen
technolog
inc
beij
china
store
use
protein
iv
load
onto
sdspage
gel
character
western
blot
use
anti
mous
monoclon
antin
monoclon
antibodi
produc
fig
character
express
e
protein
cell
seed
transfect
empti
vector
pcagg
mock
plasmid
encod
merscov
e
protein
pcaggs
e
pcaggsm
ifa
cell
seed
onto
glass
coverslip
plate
transfect
indic
express
plasmid
use
hd
transfect
reagent
promega
madison
wi
usa
h
posttransfect
cell
fix
formaldehyd
permeabil
triton
block
bsa
pb
probe
primari
antibodi
immun
mice
serum
h
room
temperatur
cell
wash
pb
incub
h
goat
antimous
ig
conjug
alexa
fluor
dilut
invitrogen
shanghai
china
cell
wash
stain
dapi
molecular
probe
detect
nuclei
fluoresc
imag
obtain
analyz
wb
sampl
collect
h
posttransfect
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
western
blot
describ
iv
immun
mous
serum
use
primari
antibodi
dilut
detect
e
protein
vaccin
iv
formul
cpg
odn
motif
contain
unmethyl
cytosin
preced
guanosin
synthes
full
phosphorothio
backbon
takara
bio
inc
around
femal
balbc
mice
divid
three
group
randomli
intramuscularli
im
inject
recombin
protein
sino
biolog
inc
beij
china
iv
protein
compris
dose
protein
adjuv
alum
cpg
quantit
determin
protein
iv
certain
amount
protein
serial
dilut
iv
load
onto
gel
character
western
blot
protein
content
iv
evalu
gray
level
screen
quantiz
control
group
immun
alum
cpg
without
immunogen
day
vaccin
alum
mix
protein
final
concentr
mgml
mix
everi
hour
maintain
homogen
shown
fig
mice
immun
three
time
interv
determin
igg
level
neutral
activ
mice
bled
vena
angulari
week
immun
ie
week
evalu
cellmedi
immun
cmi
three
mice
group
euthan
splenocyt
isol
week
last
immun
week
evalu
experi
independ
day
last
immun
remain
mice
lightli
anesthet
isofluran
transduc
intranas
plaqueform
unit
pfu
day
transduc
mice
infect
intranas
merscov
pfu
dmem
three
day
postinfect
merscov
mice
kill
lung
harvest
work
merscov
conduct
facil
antigenspecif
igg
antibodi
respons
determin
enzymelink
immunosorb
assay
elisa
describ
analysi
proteinspecif
antibodi
isotyp
recombin
protein
absorb
elisa
plate
incub
overnight
time
recombin
np
express
prokaryot
cell
purifi
nickel
column
coat
elisa
plate
analysi
npspecif
antibodi
serum
sampl
dilut
bovin
serum
albuminpb
incub
h
room
temperatur
rt
wash
follow
addit
biotinyl
antimous
igg
abcam
cambridg
uk
conjug
streptavidinhorseradish
peroxidas
hrp
bd
bioscienc
beij
china
incub
h
rt
sampl
incub
tmb
substrat
min
reaction
stop
phosphor
acid
optic
densiti
nm
measur
use
elisa
plate
reader
molecular
devic
sunnyval
ca
usa
serum
neutral
activ
determin
use
merscov
pseudoviru
system
report
neutral
antibodi
effici
calcul
rel
luciferas
unit
mock
serarel
luciferas
unit
immun
serum
given
dilut
rel
luciferas
unit
mock
sera
plaqu
reduct
neutral
assay
prnt
conduct
facil
report
briefli
heatinactiv
serum
immun
mice
serial
dilut
coincub
volum
merscov
hcovemc
mixtur
transfer
plate
confluent
vero
cell
h
viru
incub
dmem
use
control
cell
cultur
addit
h
fix
paraformaldehyd
min
plaqu
count
die
gentian
violet
plaqu
reduct
calcul
follow
inhibit
percentag
plaqu
number
incub
sera
plaqu
number
without
sera
evalu
antigenspecif
tcell
respons
vaccin
regim
interferon
ifn
enzymelink
immunospot
elispot
assay
perform
describ
synthes
peptid
librari
overlap
e
n
protein
merscov
use
spotform
cell
count
use
bioread
biosi
pasadena
ca
mice
euthan
lung
collect
ihc
examin
tissu
fix
use
neutral
buffer
formalin
embed
paraffin
section
sequenti
thick
stain
prior
examin
light
microscopi
immunohistochemistri
ihc
section
incub
rabbitserumderiv
polyclon
antibodi
nucleoprotein
sino
biolog
inc
cat
mouseserumderiv
monoclon
antibodi
protein
produc
laboratori
dilut
secondari
antibodi
goat
antirabbit
zsgbbio
beij
china
cat
goat
antimous
dilut
result
evalu
light
microscopi
multipl
independ
site
lung
tissu
sampl
use
ihc
analysi
final
four
five
slide
per
anim
evalu
statist
analys
conduct
oneway
analysi
varianc
bonferroni
posttest
use
spss
window
softwar
ver
spss
inc
chicago
il
usa
unpair
twotail
student
ttest
use
compar
mean
differ
group
valu
p
taken
indic
statist
signific
result
express
mean
standard
deviat
sd
figur
render
use
prism
softwar
graphpad
softwar
la
jolla
ca
usa
